Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140

Katia Beider, Elena Ribakovsky, Michal Abraham, Hanna Wald, Lola Weiss, Evgenia Rosenberg, Eithan Galun, Abraham Avigdor, Orly Eizenberg, Amnon Peled, Arnon Nagler*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry

Immunology and Microbiology